Treatment of secondary hyperparathyroidism of dialysis patients with calcimimetics as a valuable addition to established therapeutic means

2005 ◽  
Vol 20 (3) ◽  
pp. 399-403 ◽  
Author(s):  
Tilman B. Dr�eke
Keyword(s):  
Secondary Hyperparathyroidism ◽  
Dialysis Patients ◽  
Valuable Addition

Oral paricalcitol versus oral calcitriol in continuous ambulatory peritoneal dialysis patients with secondary hyperparathyroidism

2013 ◽  
Vol 18 (3) ◽  
pp. 507-514 ◽  
Author(s):  
Ema J. Jamaluddin ◽  
Abdul Halim Abdul Gafor ◽  
Loo Chee Yean ◽  
Rizna Cader ◽  
Rozita Mohd ◽  
...  
Keyword(s):  
Peritoneal Dialysis ◽  
Secondary Hyperparathyroidism ◽  
Continuous Ambulatory Peritoneal Dialysis ◽  
Dialysis Patients

Management of secondary hyperparathyroidism of dialysis patients

Nephrology ◽  
2003 ◽  
Vol 8 ◽  
pp. S53-S57 ◽  
Author(s):  
Tadao AKIZAWA ◽  
Motohiro KAMIMURA ◽  
Masahide MIZOBUCHI ◽  
Kazuhiro SHIIZAKI ◽  
Shinji SUMIKADO ◽  
...  
Keyword(s):  
Secondary Hyperparathyroidism ◽  
Dialysis Patients

scholarly journals Intact PTH assay overestimates true 1-84 PTH levels after maxacalcitol therapy in dialysis patients with secondary hyperparathyroidism

2004 ◽  
Vol 19 (4) ◽  
pp. 892-897 ◽  
Author(s):  
J. J. Kazama ◽  
K. Omori ◽  
N. Higuchi ◽  
N. Takahashi ◽  
Y. Ito ◽  
...  
Keyword(s):  
Secondary Hyperparathyroidism ◽  
Dialysis Patients ◽  
Intact Pth

scholarly journals FP400INFLUENCE OF THE SECONDARY HYPERPARATHYROIDISM IN IRON REQUIREMENTS IN DIALYSIS PATIENTS ON ERYTHROPOIESIS-STIMULATING AGENT THERAPY. A PROSPECTIVE CONTROLLED STUDY

2015 ◽  
Vol 30 (suppl_3) ◽  
pp. iii203-iii203
Author(s):  
Miguel Uriol Rivera ◽  
Sheila Cabello Pelegrin ◽  
Antonio Corral Baez ◽  
Sonia Jimenez Mendoza ◽  
Juan Rey Valeriano ◽  
...  
Keyword(s):  
Secondary Hyperparathyroidism ◽  
Controlled Study ◽  
Dialysis Patients ◽  
Prospective Controlled Study

Calcimimetics for the Treatment of Secondary Hyperparathyroidism in Peritoneal Dialysis Patients

2008 ◽  
Vol 28 (2_suppl) ◽  
pp. 42-46 ◽  
Author(s):  
Jean Francis ◽  
David B. Simon ◽  
Peter Jeurgensen ◽  
Fredric O. Finkelstein
Keyword(s):  
Vitamin D ◽  
Peritoneal Dialysis ◽  
Secondary Hyperparathyroidism ◽  
Hormone Secretion ◽  
Phosphate Binders ◽  
Serum Phosphate Level ◽  
Dialysis Patients ◽  
Intravenous Vitamin ◽  
Stage Renal Disease ◽  
End Stage

Secondary hyperparathyroidism is a common complication in patients with end-stage renal disease. It has been associated with increased cardiovascular events and mortality. Traditional therapy has been based on vitamin D analogs and phosphate binders; but these therapies often do not control secondary hyperparathyroidism, particularly in peritoneal dialysis patients for whom phosphate clearances are limited and intravenous vitamin D is impractical. Cinacalcet, a calcimimetic, suppresses parathormone secretion by interacting with the calcium-sensing receptor on the surface of parathyroid gland cells. The resulting suppression of parathyroid hormone secretion produces a reduction in serum phosphate level and CaxPO4 product. The present paper reviews the efficacy of cinacalcet in the management of secondary hyperparathyroidism in peritoneal dialysis patients.

Randomized controlled trial to compare the efficacy and safety of oral paricalcitol with oral calcitriol in dialysis patients with secondary hyperparathyroidism

Nephrology ◽  
2013 ◽  
Vol 18 (3) ◽  
pp. 194-200 ◽  
Author(s):  
Loke Meng Ong ◽  
Punithavathi Narayanan ◽  
Heong Keong Goh ◽  
Anita Bhajan Manocha ◽  
Ahmad Ghazali ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Secondary Hyperparathyroidism ◽  
Controlled Trial ◽  
Efficacy And Safety ◽  
Dialysis Patients ◽  
Randomized Controlled

scholarly journals Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism

2015 ◽  
Vol 87 (4) ◽  
pp. 846-856 ◽  
Author(s):  
Geert J. Behets ◽  
Goce Spasovski ◽  
Lulu R. Sterling ◽  
William G. Goodman ◽  
David M. Spiegel ◽  
...  
Keyword(s):  
Secondary Hyperparathyroidism ◽  
Bone Histomorphometry ◽  
Term Treatment ◽  
Dialysis Patients ◽  
Long Term Treatment ◽  
Before And After
Sign in / Sign up

Export Citation Format

Share Document